What is Quantum Surgical?
Founded in 2017, Quantum Surgical operates at the intersection of medical robotics and artificial intelligence. The company is best known for its Epione platform, a sophisticated system designed to assist interventional radiologists in performing minimally invasive tumor ablation. By standardizing complex procedures, the firm addresses critical gaps in cancer care, aiming to improve patient outcomes while reducing the physical burden of traditional surgical interventions. Its market position is defined by a commitment to democratizing access to high-precision oncology, a sector currently undergoing rapid digital transformation.
How much funding has Quantum Surgical raised?
Quantum Surgical has raised a total of $68M across 1 funding round:
Stock/Share Issuance
$68M
Stock/Share Issuance (2025): $68M, investors not publicly disclosed
Key Investors in Quantum Surgical
Quantum Surgical
Undisclosed investor participating in the funding round.
What's next for Quantum Surgical?
Following this major strategic investment, Quantum Surgical is well-positioned to accelerate its commercial expansion and deepen its research and development capabilities. The company is expected to focus on scaling the deployment of the Epione platform across international markets, potentially targeting broader clinical applications beyond current tumor ablation capabilities. As the firm transitions into a more mature enterprise phase, the focus will likely shift toward long-term clinical validation and the integration of advanced AI diagnostics to further enhance the precision of its robotic systems. This capital infusion provides the necessary runway to navigate the complex regulatory landscapes of global healthcare markets while maintaining its competitive edge in the high-growth medical robotics industry.
See full Quantum Surgical company page
